Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylnaltrexone for pediatric opioid-induced constipation
ACTRN12611000002987Phase 4Not yet recruiting
- Sponsor
- The Royal Children's Hospital
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of methylnaltrexone in opioid-induced constipation (OIC), sponsored by The Royal Children's Hospital. Primary endpoint: Pharmacokinetic profile of methylnaltrexone bromide. Planned start Apr 2011; status: not yet recruiting.
02
Drugs
methylnaltrexone
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on ACTRN12611000002987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000002987.